It is now generally accepted that this is mostly due to poor tumor-specific MHC class II-restricted CD4+ T helper generated in tumor-bearing hosts [115–117] and that Th cells are required for priming and clonal expansion of specific CTL following reencounter with antigen [118–121]. The gene discussed is CD4; the disease is neoplasm.